Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
47 hedge funds and large institutions have $1.1B invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
30,712% more capital invested
Capital invested by funds: $3.58M → $1.1B (+$1.1B)
4,600% more funds holding
Funds holding: 1 → 47 (+46)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$291M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$166M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$145M |
| 4 |
BlackRock
New York
|
+$121M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$69.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LTI
Laffer Tengler Investments
Nashville,
Tennessee
|
-$27.1K |
BSX.PRA Hedge Fund Activity: Q4 2021 in Review
47 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q4 2021, worth a combined $1.1B — up 30,712% from $3.58M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new BSX.PRA positions and 0 closed out — a net gain of 46 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Allianz Asset Management, opening a new position worth an estimated $291M. The largest seller was Laffer Tengler Investments, cutting an estimated $27.1K.
- 47 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q4 2021, up from 1 in Q3 2021.
- Funds reported $1.1B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q4 2021, up 30,712% quarter-over-quarter.
- 46 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q4 2021 and 0 closed out, a net change of +46 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q4 2021 was Allianz Asset Management, an estimated $291M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q4 2021 was Laffer Tengler Investments, an estimated $27.1K sold.
Based on aggregated 13F filings for Q4 2021.